<?xml version="1.0" encoding="UTF-8"?>

<article>
<articleinfo>
<bibliomisc>MEDLINE:91098050</bibliomisc>
</articleinfo>
<title>
<sentence><w c="NN">Synthesis</w> <w c="IN">of</w> <cons lex="4,19-disubstituted_derivatives" sem="G#other_organic_compound"><w c="JJ">4,19-disubstituted</w> <w c="NNS">derivatives</w></cons> <w c="IN">of</w> <cons lex="DOC" sem="G#other_organic_compound"><w c="NN">DOC</w></cons><w c=".">.</w></sentence>
<sentence><w c="NN">Radioreceptor</w> <w c="NN">assay</w> <w c="IN">of</w> <w c="DT">some</w> <cons lex="corticosteroid_derivative" sem="G#other_organic_compound"><w c="NN">corticosteroid</w> <w c="NNS">derivatives</w></cons> <w c="IN">in</w> <cons lex="human_mononuclear_leukocyte" sem="G#cell_type"><w c="JJ">human</w> <w c="JJ">mononuclear</w> <w c="NNS">leukocytes</w></cons><w c=".">.</w></sentence>
</title>
<abstract>
<sentence><w c="JJ">Several</w> <w c="JJ">new</w> <cons lex="4,19-substituted_steroid" sem="G#lipid"><w c="JJ">4,19-substituted</w> <w c="NNS">steroids</w></cons> <w c="CC">and</w> <w c="RB">previously</w> <w c="VBN">synthesized</w> <cons lex="corticosteroid" sem="G#lipid"><w c="NNS">corticosteroids</w></cons> <w c="VBD">were</w> <w c="VBN">assayed</w> <w c="IN">for</w> <w c="NN">affinity</w> <w c="TO">to</w> <cons lex="type_1_receptor" sem="G#protein_family_or_group"><w c="NN">type</w> <w c="CD">1</w> <w c="NNS">receptors</w></cons> <w c="IN">in</w> <cons lex="human_mononuclear_leukocyte" sem="G#cell_type"><w c="JJ">human</w> <w c="JJ">mononuclear</w> <w c="NNS">leukocytes</w></cons><w c=".">.</w></sentence>
<sentence><cons lex="11_beta,19-epoxy-4,21-dihydroxypregn-4-ene-3,20-dione" sem="G#other_organic_compound"><w c="CD">11</w> <w c="NN">beta,19-epoxy-4,21-dihydroxypregn-4-ene-3,20-dione</w></cons> <w c="(">(</w><w c="CD">2</w><w c=")">)</w> <w c="VBD">was</w> <w c="VBN">hydrogenated</w> <w c="IN">with</w> <cons lex="Pd-C" sem="G#other_organic_compound"><w c="NN">Pd-C</w></cons> <w c="TO">to</w> <w c="VB">yield</w> <w c="DT">a</w> <w c="NN">mixture</w> <w c="IN">of</w> <w c="DT">all</w> <w c="CD">four</w> <cons lex="dihydro_derivative" sem="G#other_organic_compound"><w c="NN">dihydro</w> <w c="NNS">derivatives</w></cons> <w c="CD">5</w><w c=",">,</w> <w c="VBN">accompanied</w> <w c="IN">by</w> <cons lex="4,21-diacetoxy-11_beta,19-epoxy-3-hydroxypregnan-20-one" sem="G#other_organic_compound"><w c="NN">4,21-diacetoxy-11</w> <w c="NN">beta,19-epoxy-3-hydroxypregnan-20-one</w></cons> <w c="(">(</w><w c="CD">6</w><w c=")">)</w> <w c="CC">and</w> <cons lex="21-acetoxy-11_beta,19-epoxy-4-hydroxypregnane-3,20-dione" sem="G#other_organic_compound"><w c="NN">21-acetoxy-11</w> <w c="NN">beta,19-epoxy-4-hydroxypregnane-3,20-dione</w></cons> <w c="(">(</w><w c="CD">7</w><w c=")">)</w><w c=".">.</w></sentence>
<sentence><w c="IN">With</w> <cons lex="hot_acetic_+_p-toluenesulfonic_acid" sem="G#other_organic_compound"><w c="JJ">hot</w> <w c="JJ">acetic</w> <w c="CC">+</w> <w c="JJ">p-toluenesulfonic</w> <w c="NN">acid</w></cons> <w c="CD">5</w> <w c="VBD">underwent</w> <w c="NN">rearrangement</w> <w c="TO">to</w> <cons lex="21-acetoxy-11_beta,19-epoxypregn-5-ene-4,20-dione" sem="G#other_organic_compound"><w c="NN">21-acetoxy-11</w> <w c="NN">beta,19-epoxypregn-5-ene-4,20-dione</w></cons> <w c="(">(</w><w c="CD">8</w><w c=")">)</w> <cons lex="Pd-C" sem="G#other_organic_compound"><w c="NN">Pd-C</w></cons> <w c="NN">hydrogenation</w> <w c="IN">of</w> <cons lex="3,21-diacetoxy-5_beta,19-cyclopregna-2,9(11)-diene-4,20-dione" sem="G#other_organic_compound"><w c="NN">3,21-diacetoxy-5</w> <w c="NN">beta,19-cyclopregna-2,9(11)-diene-4,20-dione</w></cons> <w c="(">(</w><w c="CD">10</w><w c=")">)</w> <w c="VBD">gave</w> <cons lex="3,21-diacetoxy-5_beta,19-cyclopregn-5-ene-4,20-dione" sem="G#other_organic_compound"><w c="NN">3,21-diacetoxy-5</w> <w c="NN">beta,19-cyclopregn-5-ene-4,20-dione</w></cons> <w c="(">(</w><w c="CD">11</w><w c=")">)</w> <w c="CC">and</w> <w c="DT">the</w> <cons lex="9,11-dihydro_derivative" sem="G#other_organic_compound"><w c="NN">9,11-dihydro</w> <w c="NN">derivative</w></cons> <w c="IN">of</w> <w c="DT">the</w> <w c="JJ">latter</w><w c=".">.</w></sentence>
<sentence><w c="NN">Treatment</w> <w c="IN">of</w> <w c="CD">10</w> <w c="IN">with</w> <cons lex="warm_HCl" sem="G#inorganic"><w c="JJ">warm</w> <w c="NN">HCl</w></cons> <w c="JJ">furnished</w> <cons lex="19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione" sem="G#other_organic_compound"><w c="NN">19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione</w></cons> <w c="CD">(13)</w><w c=".">.</w></sentence>
<sentence><cons lex="Pd-C" sem="G#other_organic_compound"><w c="NN">Pd-C</w></cons> <w c="NN">hydrogenation</w> <w c="IN">of</w> <w c="PRP$">its</w> <cons lex="diacetate_14" sem="G#other_organic_compound"><w c="NN">diacetate</w> <w c="CD">14</w></cons> <w c="VBD">afforded</w> <w c="DT">the</w> <cons lex="4,5-dihydro_derivative_18,_19-chloro-21-acetoxypregn-9(11)-en-20-one" sem="G#other_organic_compound"><w c="NN">4,5-dihydro</w> <w c="NN">derivative</w> <w c="NN">18, 19-chloro-21-acetoxypregn-9(11)-en-20-one</w></cons> <w c="(">(</w><w c="CD">15</w><w c=")">)</w><w c=",">,</w> <w c="PRP$">its</w> <cons lex="4-acetoxy_derivative" sem="G#other_organic_compound"><w c="NN">4-acetoxy</w> <w c="NN">derivative</w></cons> <w c="CD">16</w> <w c="CC">and</w> <w c="DT">the</w> <cons lex="3,4-diacetoxy_derivative" sem="G#other_organic_compound"><w c="NN">3,4-diacetoxy</w> <w c="NN">derivative</w></cons> <w c="CD">17</w><w c=".">.</w></sentence>
<sentence><w c="WRB">When</w> <w c="VBN">tested</w> <w c="IN">in</w> <w c="DT">a</w> <cons lex="radioreceptor_assay" sem="G#other_name"><w c="NN">radioreceptor</w> <w c="NN">assay</w></cons> <w c="IN">in</w> <cons lex="human_mononuclear_leukocyte" sem="G#cell_type"><w c="JJ">human</w> <w c="JJ">mononuclear</w> <w c="NNS">leukocytes</w></cons> <w c="DT">the</w> <w c="VBN">synthesized</w> <w c="NNS">compounds</w> <w c="VBD">showed</w> <w c="RB">only</w> <w c="JJ">low</w> <cons lex="relative_binding_affinity" sem="G#other_name"><w c="JJ">relative</w> <w c="NN">binding</w> <w c="NNS">affinities</w></cons> <w c="(">(</w><cons lex="RBA" sem="G#other_name"><w c="NNS">RBA</w></cons><w c=")">)</w> <w c="TO">to</w> <cons lex="type_1_receptor" sem="G#protein_family_or_group"><w c="NN">type</w> <w c="CD">1</w> <w c="NN">receptor</w></cons><w c=",">,</w> <w c="DT">the</w> <w c="JJS">highest</w> <w c="VBG">being</w> <w c="CD">0.72</w><w c="NN">%</w> <w c="IN">for</w> <w c="CD">13</w> <w c="(">(</w><cons lex="aldosterone" sem="G#lipid"><w c="NN">aldosterone</w></cons> <w c="JJ">=</w> <w c="CD">100</w><w c="NN">%</w><w c=")">)</w><w c=".">.</w></sentence>
<sentence><w c="IN">For</w> <w c="NN">comparison</w><w c=",">,</w> <w c="JJ">other</w> <cons lex="RBA" sem="G#other_name"><w c="NNS">RBA</w></cons> <w c="IN">in</w> <w c="DT">this</w> <w c="NN">system</w> <w c="VBD">were</w><w c=":">:</w> <cons lex="19-noraldosterone" sem="G#lipid"><w c="NN">19-noraldosterone</w></cons><w c=",">,</w> <w c="CD">20</w><w c="NN">%</w><w c=":">;</w> <cons lex="18-deoxyaldosterone" sem="G#lipid"><w c="NN">18-deoxyaldosterone</w></cons><w c=",">,</w> <w c="CD">5.8</w><w c="NN">%</w><w c=":">;</w> <cons lex="18-deoxy-19-noraldosterone" sem="G#lipid"><w c="NN">18-deoxy-19-noraldosterone</w></cons><w c=",">,</w> <w c="CD">4.7</w><w c="NN">%</w><w c=":">;</w> <cons lex="18,21-anhydroaldosterone" sem="G#lipid"><w c="NN">18,21-anhydroaldosterone</w></cons><w c=",">,</w> <w c="CD">0.37</w><w c="NN">%</w><w c=":">;</w> <cons lex="17-isoaldosterone" sem="G#lipid"><w c="NN">17-isoaldosterone</w></cons><w c=",">,</w> <w c="CD">7.6</w><w c="NN">%</w> <w c="CC">and</w> <cons lex="apoaldosterone" sem="G#lipid"><w c="NN">apoaldosterone</w></cons><w c=",">,</w> <w c="CD">4.3</w><w c="NN">%</w></sentence>
</abstract>
</article>
